The results (Figure 1) indicated that the IC50 values of TBs-C were significantly lower than those of TP in several lung cancer cells (p < 0.05), which alluded that TBs-C may exhibit a stronger antitumor activity on human NSCLC cells than TP. The gene discussed is SALL1; the disease is non-small cell lung carcinoma.